Home · Peptides · Bonomarlot
THE PEPTIDE APP FIELD GUIDE · Healing SERIES FIELD SPECIMEN
Healing CATEGORY

Bonomarlot

THE BLOOD BUILDER

A-20 bone marrow peptide bioregulator

Bonomarlot is derived from animal bone marrow and contains peptides that help restore blood cell production. It targets the stem cells in your bone marrow, helping them produce more red blood cells, white blood cells, and platelets. This makes it valuable for immune support, recovery from illness, and anti-aging as blood production naturally declines with age.

Bonomarlot
Bonomarlot
Bonomarlot

Bonomarlot Evidence Snapshot

How these guides are reviewed
REGULATORY STATUS

Not FDA approved · research use only

DOSING GUIDANCE

Reviewed by our clinical team

LINKED EVIDENCE

1 research sources

CONTENT UPDATED

Aug 28, 2026

Dose and schedule recommendations shown below come from The Peptide App Clinical Team. Research links are provided so readers can inspect the supporting evidence directly. Review the sources.

Quick Answers About Bonomarlot

◆

Is Bonomarlot FDA approved?

No. This profile records Bonomarlot as not FDA approved and for research use only.

MORE CONTEXT ›

Review the regulatory and source details on this page for the current context.

◆

What dose does The Peptide App Clinical Team recommend for Bonomarlot?

Dose: 30 mg daily.

MORE CONTEXT ›

Schedule: daily. Cycle: 4 weeks on, 12 weeks off. This is clinical-team guidance for reference and does not replace individualized instructions from a licensed clinician.

◆

What research supports this Bonomarlot guide?

This guide links to 1 curated or current research sources.

MORE CONTEXT ›

Open the research section to inspect the source titles, publication details, study types, and available abstracts directly.

Studied Effects & Mechanisms

Gene Activation

Short peptides bind to bone marrow DNA to restore protein synthesis

Blood Cell Production

Stimulates stem cells to produce red and white blood cells

Immune Boost

Increases lymphocyte, neutrophil, and monocyte production

People recovering from chemotherapy or radiation
Those with weakened immune systems
Aging individuals with declining blood counts
Athletes needing enhanced recovery

Bonomarlot Research

Live research temporarily unavailable

The live research feed did not return papers for this page. The curated references below remain available for crawlable source context.